How to best manage cytomegalovirus infection in the allogeneic stem cell transplant setting: future prospects

被引：0

作者：

Solano, Carlos ^{[1
,2
]}

Navarro, David ^{[3
,4
]}

机构：

[1] Inst Invest INCLIVA, Hosp Clin Univ, Hematol Serv, Valencia, Spain

[2] Univ Valencia, Sch Med, Dept Med, E-46003 Valencia, Spain

[3] Inst Invest INCLIVA, Hosp Clin Univ, Microbiol Serv, Valencia, Spain

[4] Univ Valencia, Sch Med, Dept Microbiol, E-46003 Valencia, Spain

来源：

FUTURE VIROLOGY | 2016年 / 11卷 / 09期

关键词：

cytomegalovirus; pre-emptive antiviral therapy; T-cell immunity; universal prophylaxis; viral doubling time; viremia; TIME PCR ASSAYS; VIRAL LOAD; RECIPIENTS; THERAPY; ERA;

D O I：

10.2217/fvl-2016-0086

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

[No abstract available]

引用

页码：603 / 606

页数：4

共 18 条

[1] Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCT [J].

Avetisyan, G. ;

Aschan, J. ;

Haegglund, H. ;

Ringden, O. ;

Ljungman, P. .

BONE MARROW TRANSPLANTATION, 2007, 40 (09) :865-869

[2] Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies [J].

Boeckh, M ;

Nichols, WG ;

Papanicolaou, G ;

Rubin, R ;

Wingard, JR ;

Zaia, Y .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (09) :543-558

[3] Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: A randomized double-blind study [J].

Boeckh, M ;

Gooley, TA ;

Myerson, D ;

Cunningham, T ;

Schoch, G ;

Bowden, RA .

BLOOD, 1996, 88 (10) :4063-4071

[4] How I treat cytomegalovirus in hematopoietic cell transplant recipients [J].

Boeckh, Michael ;

Ljungman, Per .

BLOOD, 2009, 113 (23) :5711-5719

[5] Comparative Evaluation of Three Automated Systems for DNA Extraction in Conjunction with Three Commercially Available Real-Time PCR Assays for Quantitation of Plasma Cytomegalovirus DNAemia in Allogeneic Stem Cell Transplant Recipients [J].

Bravo, Dayana ;

Angeles Clari, Maria ;

Costa, Elisa ;

Munoz-Cobo, Beatriz ;

Solano, Carlos ;

Jose Remigia, Maria ;

Navarro, David .

JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (08) :2899-2904

[6]

Fryer JF., 2010, WHOBS102138

[7] Early Kinetics of Plasma Cytomegalovirus DNA Load in Allogeneic Stem Cell Transplant Recipients in the Era of Highly Sensitive Real-Time PCR Assays: Does It Have Any Clinical Value? [J].

Gimenez, Estela ;

Munoz-Cobo, Beatriz ;

Solano, Carlos ;

Amat, Paula ;

Navarro, David .

JOURNAL OF CLINICAL MICROBIOLOGY, 2014, 52 (02) :654-656

[8] Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study [J].

Green, Margaret L. ;

Leisenring, Wendy ;

Xie, Hu ;

Mast, T. Christopher ;

Cui, Yadong ;

Sandmaier, Brenda M. ;

Sorror, Mohamed L. ;

Goyal, Sonia ;

Oezkoek, Sezen ;

Yi, Jessica ;

Sahoo, Farah ;

Kimball, Louise E. ;

Jerome, Keith R. ;

Marks, Morgan A. ;

Boeckh, Michael .

LANCET HAEMATOLOGY, 2016, 3 (03) :E119-E127

[9] Commutability of the First World Health Organization International Standard for Human Cytomegalovirus [J].

Hayden, R. T. ;

Preiksaitis, J. ;

Tong, Y. ;

Pang, X. ;

Sun, Y. ;

Tang, L. ;

Cook, L. ;

Pounds, S. ;

Fryer, J. ;

Caliendo, A. M. .

JOURNAL OF CLINICAL MICROBIOLOGY, 2015, 53 (10) :3325-3333

[10] Characterization of Cytomegalovirus Breakthrough Events in a Phase 2 Prophylaxis Trial of Letermovir (AIC246, MK 8228) [J].

Lischka, Peter ;

Michel, Detlef ;

Zimmermann, Holger .

JOURNAL OF INFECTIOUS DISEASES, 2016, 213 (01) :23-30

← 1 2 →